No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:113421400-113448400 |
Weak transcription |
ES-I3 Cell Line |
embryonic stem cell
|
2 |
chr2:113421600-113438400 |
Weak transcription |
Psoas Muscle |
Psoas
|
3 |
chr2:113422800-113438200 |
Weak transcription |
Brain Cingulate Gyrus |
brain
|
4 |
chr2:113423200-113445000 |
Weak transcription |
Fetal Brain Male |
brain
|
5 |
chr2:113423400-113448400 |
Weak transcription |
Brain Inferior Temporal Lobe |
brain
|
6 |
chr2:113432600-113439400 |
Weak transcription |
Placenta |
Placenta
|
7 |
chr2:113432600-113440800 |
Weak transcription |
Spleen |
Spleen
|
8 |
chr2:113433000-113438200 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
9 |
chr2:113436000-113438200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
10 |
chr2:113436200-113438200 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
11 |
chr2:113436800-113437400 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
12 |
chr2:113436800-113437400 |
Enhancers |
Skeletal Muscle Male |
skeletal muscle
|
13 |
chr2:113436800-113438200 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
14 |
chr2:113436800-113438800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
15 |
chr2:113437000-113437400 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
16 |
chr2:113437000-113437400 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
17 |
chr2:113437000-113437400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
18 |
chr2:113437000-113437400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
19 |
chr2:113437000-113437400 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
20 |
chr2:113437000-113437400 |
Enhancers |
Adipose Nuclei |
Adipose
|
21 |
chr2:113437000-113437400 |
Enhancers |
Lung |
lung
|
22 |
chr2:113437000-113437400 |
Flanking Active TSS |
Skeletal Muscle Female |
skeletal muscle
|
23 |
chr2:113437000-113437400 |
Enhancers |
NHDF-Ad |
bronchial
|
24 |
chr2:113437000-113437400 |
Enhancers |
NHLF |
lung
|
25 |
chr2:113437000-113437600 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
26 |
chr2:113437000-113437600 |
Enhancers |
HUVEC |
blood vessel
|
27 |
chr2:113437000-113438200 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
28 |
chr2:113437000-113438200 |
Enhancers |
Colon Smooth Muscle |
Colon
|
29 |
chr2:113437000-113438200 |
Enhancers |
HMEC |
breast
|
30 |
chr2:113437000-113438200 |
Enhancers |
Osteobl |
bone
|
31 |
chr2:113437000-113438400 |
Enhancers |
K562 |
blood
|
32 |
chr2:113437000-113445800 |
Enhancers |
Hela-S3 |
cervix
|
33 |
chr2:113437200-113437400 |
Enhancers |
ES-WA7 Cell Line |
embryonic stem cell
|
34 |
chr2:113437200-113437400 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
35 |
chr2:113437200-113437400 |
Enhancers |
Esophagus |
oesophagus
|
36 |
chr2:113437200-113437400 |
Bivalent Enhancer |
HepG2 |
liver
|
37 |
chr2:113437200-113437600 |
Weak transcription |
Primary neutrophils fromperipheralblood |
blood
|
38 |
chr2:113437200-113437600 |
Enhancers |
Fetal Brain Female |
brain
|
39 |
chr2:113437200-113437600 |
Flanking Active TSS |
NHEK |
skin
|
40 |
chr2:113437200-113438200 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
41 |
chr2:113437200-113438200 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|